Ultragenyx Pharmaceutical Inc.

(RARE) Trade

By |

Profile

Ultragenyx Pharmaceutical Inc is biopharmaceutical company. It is engaged identification, acquisition, development and commercialization of novel products for treatment of rare & ultra-rare diseases, with a focus on debilitating genetic diseases.

Contact Information

Website: www.ultragenyx.com
Main Phone: +1 415 483-8800
Address: 60 Leveroni Court
State: CA
City / Town: Novato
Country: USA
Postal Code: 94949

Issuer Information

Exchange: NGS
CEO: Emil D. Kakkis
Employees: 520
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 84.87 $ -1.42 (-1.65%)
Last Price 84.87 Change $ -1.42 Change % -1.65 Tick N/A
Bid 60.28 Bid Size 100.00 Ask N/A Ask Size 0.00
Open 86.07 High 86.54 Low 84.26 Prev Close 86.29
Last Trade Volume 561,061 52 Wk Hi 88.41 52 Wk Low 41.67
Market Cap 4.3 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 50,182,357.00 EPS (TTM) -4.21 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 26 56
Number of Buys 10 29
Number of Sells 16 27
Net Activity -10238 91795
Last 10 Buys Shares
Emil D. Kakkis 1,000
Emil D. Kakkis 1,000
Thomas R. Kassberg 1,000
Matthew K. Fust 1,000
Shalini Sharp 1,000
Last 10 Sell Shares
Shalini Sharp 1,000
Matthew K. Fust 1,000
Shalini Sharp 1,000
Karah Parschauer 1,000
Theodore A. Huizenga 1,000
Shalini Sharp 1,000
Shalini Sharp 1,000
William E. Aliski 1,000
William E. Aliski 1,000
Theodore A. Huizenga 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 80 80 80 80
Low Target Price Estimate 57 57 57 57
Mean Target Price Estimate 70.81 70.81 70.81 70.81
Standard Deviation 5.78 5.78 5.78 5.78
Date of Most Recent Estimate 05/17/18 05/17/18 05/17/18 06/13/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 13 14 12 11
Moderate Buy 1 1 1 1
Hold 2 2 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.31 1.29 1.53 1.56